Crossmark

Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson’s disease

Crossref DOI link: https://doi.org/10.1186/s13024-015-0067-y

Published Online: 2016-01-13

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Baranyi, Mária

Porceddu, Pier Francesca

Gölöncsér, Flóra

Kulcsár, Szabina

Otrokocsi, Lilla

Kittel, Ágnes

Pinna, Annalisa

Frau, Lucia

Huleatt, Paul B.

Khoo, Mui-Ling

Chai, Christina L. L.

Dunkel, Petra

Mátyus, Peter

Morelli, Micaela

Sperlágh, Beáta
Funding

Funding for this research was provided by:

Hungarian Research and Development Fund (NN107234)

Hungarian Office of Science and Technology (TÉT_10-1-2011-0050)

European Research Council (BE) (294313-SERRACO)

Hungarian Brain Research Program (KTIA_13_NAP-A-III/1)

Agency for Science Technology and Research, Singapore (1021490113)

Hungarian Office of Science and Technology